Search

everythinglearnresearchcommunity

for

Search:↓

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

TRα and CRABPII genes change their activity levels during goat fetal skin development.

Concurrent laser and isotretinoin treatment improves acne scars more than delayed treatment.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

Baricitinib helps patients with severe alopecia areata regrow hair.

Cardamonin may help treat oral cancer by promoting cell death and stopping cancer cell growth.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Adapalene 0.1% effectively reduces acne by decreasing comedones and altering skin properties.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

ADF8 and ADF11 help root hairs grow by responding to hormones and environmental signals.

Muscarinic acetylcholine receptors in skin cells help regulate and promote hair growth.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

p63 controls Satb1 to help skin develop properly.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

Lipin-1 is important for skin cell differentiation and skin barrier function.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.